Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Other Non-Current Liabilities (2016 - 2025)

Traws Pharma (TRAW) has disclosed Other Non-Current Liabilities for 11 consecutive years, with $100000.0 as the latest value for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities fell 99.76% year-over-year to $100000.0; the TTM value through Dec 2025 reached $100000.0, down 99.76%, while the annual FY2025 figure was $100000.0, 99.76% down from the prior year.
  • Other Non-Current Liabilities hit $100000.0 in Q4 2025 for Traws Pharma, up from $11000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $42.5 million in Q4 2024 and bottomed at $8000.0 in Q2 2025.
  • Average Other Non-Current Liabilities over 3 years is $6.3 million, with a median of $154000.0 recorded in 2025.
  • Year-over-year, Other Non-Current Liabilities skyrocketed 261.36% in 2021 and then plummeted 99.76% in 2025.
  • Traws Pharma's Other Non-Current Liabilities stood at $530000.0 in 2021, then surged by 7917.74% to $42.5 million in 2024, then tumbled by 99.76% to $100000.0 in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $100000.0, $11000.0, and $8000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.